ReviewJournal of clinical medicine2025

Immune Checkpoint Inhibitors and Allograft Rejection Risk: Emerging Evidence Regarding Their Use in Kidney Transplant Recipients.

Muhammad Ali Khan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.